{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:03:16Z","timestamp":1791327796790,"version":"4.3.1"},"reference-count":76,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"121","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Transl. Med."],"published-print":{"date-parts":[[2012,2,15]]},"abstract":"<jats:p>Two high-affinity T-type calcium channel blockers attenuate neural activity in the thalamus and suppress seizures in a genetic model of absence epilepsy.<\/jats:p>","DOI":"10.1126\/scitranslmed.3003120","type":"journal-article","created":{"date-parts":[[2012,2,15]],"date-time":"2012-02-15T15:20:32Z","timestamp":1329319232000},"source":"Crossref","is-referenced-by-count":192,"title":["T-Type Calcium Channel Blockers That Attenuate Thalamic Burst Firing and Suppress Absence Seizures"],"prefix":"10.1126","volume":"4","author":[{"given":"Elizabeth","family":"Tringham","sequence":"first","affiliation":[{"name":"Zalicus Pharmaceuticals Ltd., Suite 301, 2389 Health Sciences Mall, Vancouver, British Columbia V6T 1Z3, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim L.","family":"Powell","sequence":"additional","affiliation":[{"name":"Department of Medicine, Royal Melbourne Hospital, University of Melbourne, 4th Floor, Clinical Sciences Building, Royal Parade, Parkville, Victoria 3050, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart M.","family":"Cain","sequence":"additional","affiliation":[{"name":"Michael Smith Laboratories, University of British Columbia, Room 219, 2185 East Mall, Vancouver, British Columbia V6T 1Z4, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristy","family":"Kuplast","sequence":"additional","affiliation":[{"name":"Zalicus Pharmaceuticals Ltd., Suite 301, 2389 Health Sciences Mall, Vancouver, British Columbia V6T 1Z3, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janette","family":"Mezeyova","sequence":"additional","affiliation":[{"name":"Zalicus Pharmaceuticals Ltd., Suite 301, 2389 Health Sciences Mall, Vancouver, British Columbia V6T 1Z3, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjula","family":"Weerapura","sequence":"additional","affiliation":[{"name":"Zalicus Pharmaceuticals Ltd., Suite 301, 2389 Health Sciences Mall, Vancouver, British Columbia V6T 1Z3, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus","family":"Eduljee","sequence":"additional","affiliation":[{"name":"Zalicus Pharmaceuticals Ltd., Suite 301, 2389 Health Sciences Mall, Vancouver, British Columbia V6T 1Z3, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinpo","family":"Jiang","sequence":"additional","affiliation":[{"name":"Zalicus Pharmaceuticals Ltd., Suite 301, 2389 Health Sciences Mall, Vancouver, British Columbia V6T 1Z3, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Smith","sequence":"additional","affiliation":[{"name":"Zalicus Pharmaceuticals Ltd., Suite 301, 2389 Health Sciences Mall, Vancouver, British Columbia V6T 1Z3, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerrie-Lynn","family":"Morrison","sequence":"additional","affiliation":[{"name":"Zalicus Pharmaceuticals Ltd., Suite 301, 2389 Health Sciences Mall, Vancouver, British Columbia V6T 1Z3, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel C.","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Medicine, Royal Melbourne Hospital, University of Melbourne, 4th Floor, Clinical Sciences Building, Royal Parade, Parkville, Victoria 3050, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Braine","sequence":"additional","affiliation":[{"name":"Department of Medicine, Royal Melbourne Hospital, University of Melbourne, 4th Floor, Clinical Sciences Building, Royal Parade, Parkville, Victoria 3050, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Rind","sequence":"additional","affiliation":[{"name":"Department of Medicine, Royal Melbourne Hospital, University of Melbourne, 4th Floor, Clinical Sciences Building, Royal Parade, Parkville, Victoria 3050, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Fee-Maki","sequence":"additional","affiliation":[{"name":"Zalicus Pharmaceuticals Ltd., Suite 301, 2389 Health Sciences Mall, Vancouver, British Columbia V6T 1Z3, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Parker","sequence":"additional","affiliation":[{"name":"Zalicus Pharmaceuticals Ltd., Suite 301, 2389 Health Sciences Mall, Vancouver, British Columbia V6T 1Z3, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Pajouhesh","sequence":"additional","affiliation":[{"name":"Zalicus Pharmaceuticals Ltd., Suite 301, 2389 Health Sciences Mall, Vancouver, British Columbia V6T 1Z3, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjeet","family":"Parmar","sequence":"additional","affiliation":[{"name":"Zalicus Pharmaceuticals Ltd., Suite 301, 2389 Health Sciences Mall, Vancouver, British Columbia V6T 1Z3, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence J.","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"Department of Medicine, Royal Melbourne Hospital, University of Melbourne, 4th Floor, Clinical Sciences Building, Royal Parade, Parkville, Victoria 3050, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terrance P.","family":"Snutch","sequence":"additional","affiliation":[{"name":"Michael Smith Laboratories, University of British Columbia, Room 219, 2185 East Mall, Vancouver, British Columbia V6T 1Z4, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0074-7742(08)60611-X"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2009.06.007"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.2174\/157488909788453022"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2009.02.036"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-009-0772-x"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2009.03404.x"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4020-6191-2_8"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1124\/pr.57.4.5"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.19-06-01895.1999"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0082(97)00091-9"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2006.108498"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.15-04-03110.1995"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00667.2002"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1535-7597.2002.00024.x"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.60.5.1121"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2007.00009.x"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(01)00343-9"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5546-03.2004"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2081-08.2009"},{"key":"e_1_3_2_21_2","first-page":"71","article-title":"Cortical and thalamic lesions in rats with genetic absence epilepsy","volume":"35","author":"Vergnes M.","year":"1992","unstructured":"Vergnes M., Marescaux C., Cortical and thalamic lesions in rats with genetic absence epilepsy. J. Neural Transm. Suppl. 35, 71\u201383 (1992).","journal-title":"J. Neural Transm. Suppl."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5295-08.2009"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10607"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21169"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2006.06.073"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-1809.2006.00332.x"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.9491"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C400006200"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20458"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2006.00482.x"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0847-05.2005"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1817-06.2007"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0902014"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1602\/neurorx.2.4.662"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.51.6.1077"},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0026-895X(25)09804-9","article-title":"Slow binding of phenytoin to inactivated sodium channels in rat hippocampal neurons","volume":"46","author":"Kuo C. C.","year":"1994","unstructured":"Kuo C. C., Bean B. P., Slow binding of phenytoin to inactivated sodium channels in rat hippocampal neurons. Mol. Pharmacol. 46, 716\u2013725 (1994).","journal-title":"Mol. Pharmacol."},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701221"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.09.008"},{"key":"e_1_3_2_39_2","first-page":"37","article-title":"Genetic absence epilepsy in rats from Strasbourg\u2014A review","volume":"35","author":"Marescaux C.","year":"1992","unstructured":"Marescaux C., Vergnes M., Depaulis A., Genetic absence epilepsy in rats from Strasbourg\u2014A review. J. Neural Transm. Suppl. 35, 37\u201369 (1992).","journal-title":"J. Neural Transm. Suppl."},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2007.05348.x"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2004.11.022"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2008.01759.x"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-328X(99)00307-1"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.12-10-03804.1992"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2005.086579"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706020"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2006.110395"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.2174\/187152706779025526"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2002.1154"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1989.sp017705"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.16-17-05301.1996"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1984.51.6.1196"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1984.sp015154"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1038\/297406a0"},{"key":"e_1_3_2_55_2","unstructured":"A. L. Sherwin Ethosuximide: Clinical use in Antiepileptic Drugs (Raven Press New York 1989) pp. 685\u2013689."},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2003.09.026"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(03)00060-3"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2007.05.030"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-04-01480.2002"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2003.046573"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0753-07.2007"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1824881"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm800830n"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1002\/neu.20107"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-15-06362.2002"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.FP0050691"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0408089101"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409644102"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.171058"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(96)00254-0"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-09-03645.2002"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ddmec.2006.10.001"},{"key":"e_1_3_2_73_2","doi-asserted-by":"crossref","unstructured":"Marescaux C. Vergnes M. Micheletti G. Depaulis A. Reis J. Rumbach L. Warter J. M. Kurtz D. A genetic form of petit mal absence in Wistar rats. Rev. Neurol. 140 63\u201366 (1984). PubMed","DOI":"10.1007\/BF01252613"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02229083"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.104968"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2007.09.026"},{"key":"e_1_3_2_77_2","first-page":"179","article-title":"GABAB receptor antagonists: Potential new anti-absence drugs","volume":"35","author":"Marescaux C.","year":"1992","unstructured":"Marescaux C., Vergnes M., Bernasconi R., GABAB receptor antagonists: Potential new anti-absence drugs. J. Neural Transm. Suppl. 35, 179\u2013188 (1992).","journal-title":"J. Neural Transm. Suppl."}],"container-title":["Science Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/scitranslmed.3003120","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T17:55:20Z","timestamp":1742493320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/scitranslmed.3003120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,15]]},"references-count":76,"journal-issue":{"issue":"121","published-print":{"date-parts":[[2012,2,15]]}},"alternative-id":["10.1126\/scitranslmed.3003120"],"URL":"https:\/\/doi.org\/10.1126\/scitranslmed.3003120","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13869959.15418091","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.13869959.15402062","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.13869959.15307061","asserted-by":"object"}]},"ISSN":["1946-6234","1946-6242"],"issn-type":[{"value":"1946-6234","type":"print"},{"value":"1946-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,15]]}}}